SCHEMBL770846

SCHEMBL770846

Cc1csc(N(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840510 0.81
SCHEMBL232983 0.78 SMN1; SMN2 (0.40)
SCHEMBL685578 0.76 SMN1; SMN2 (0.43)
SCHEMBL18678342 0.75 MEN1 (0.40)
SCHEMBL9955496 0.74 SLC12A5 (0.49)
SCHEMBL13653784 0.74 NPC1 (0.54)
SCHEMBL13634342 0.74 NOS1 (0.38)
SCHEMBL5637600 0.73
SCHEMBL3922619 0.73
SCHEMBL770845 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3597649-B1 COMPOSITIONS CONTAINING SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE CAYMAN LTD (KY) 2021-10-13 EP claimed
EP-3134413-B1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE CAYMAN LTD (KY) 2019-09-11 EP claimed
US-9932345-B2 Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2018-04-03 US claimed
US-20170057967-A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE LLC 2017-03-02 US claimed
EP-3134413-A1 SUBSTITUTED [1,2,4]TRIAZOLO [1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS Dart Neuroscience (Cayman) Ltd (KY) 2017-03-01 EP claimed
WO-2015164508-A1 SUBSTITUTED [1,2,4] TRIAZOLO [1,5-A] PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE, LLC (US) 2015-10-29 WO claimed
US-12630556-B2 Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors DART NEUROSCIENCE LLC (US) 2026-05-19 US disclosed
US-20250092047-A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE LLC 2025-03-20 US disclosed
US-20250059178-A1 N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS Aucentra Thereapeutics Pty LTD (AU) 2025-02-20 US disclosed
US-11970491-B2 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds AUCENTRA THERAPEUTICS PTY LTD (AU) 2024-04-30 US disclosed
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 US disclosed
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 US disclosed
US-20230192698-A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE LLC (US) 2023-06-22 US disclosed
EP-0465403-A1 Pressure sensitive recording and transfer material CIBA-GEIGY AG (CH) 1992-01-08 EP disclosed
EP-0465402-A1 Heat sensitive recording material CIBA-GEIGY AG (CH) 1992-01-08 EP disclosed
EP-0463987-A1 Pressure sensitive recording material CIBA-GEIGY AG (CH) 1992-01-02 EP disclosed
US-5024988-A Color reaction system comprising a polycyclic heterocyclic compound, a leuko dye to form a chromogen with the first compound, a Lewis acid and developer CIBA-GEIGY CORPORATION (US) 1991-06-18 US disclosed
EP-0373110-A2 Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY AG (CH) 1990-06-13 EP disclosed
US-4269978-A CHROMOGENS; ENCAPSULATED FOR REPRODUCTION AND RECORDING PURPOSES CIBA-GEIGY CORPORATION (US) 1981-05-26 US disclosed
US-4100169-A USEFUL AS COLOR FORMERS CIBA-GEIGY CORPORATION (US) 1978-07-11 US disclosed